Literature DB >> 4315958

Biochemical consequences of type 2 adenovirus and Simian virus 40 double infections of African green monkey kidney cells.

M P Friedman, M J Lyons, H S Ginsberg.   

Abstract

African green monkey kidney (AGMK) cells were nonpermissive hosts for type 2 adenovirus although the restriction was not complete; when only 3 plaque-forming units/cell was employed as the inoculum, the viral yield was about 0.1% of the maximum virus produced when simian virus 40 (SV40) enhanced adenovirus multiplication. The viral yield of cells infected only with type 2 adenovirus increased as the multiplicity of infection was increased. Type 2 adenovirus could infect almost all AGMK cells in culture; adenovirus-specific early proteins and DNA were synthesized in most cells, but small amounts of late proteins were made in relatively few cells. Even when cells were infected with both SV40 and adenovirus, only about 50% were permissive for synthesis of adenovirus capsid proteins. Approximately the same quantity of adenovirus deoxyribonucleic acid (DNA) was synthesized in the restricted as in the SV40-enhanced infection. However, in cells infected with SV40 and type 2 adenovirus, replication of SV40 DNA was blocked, multiplication of SV40 was accordingly inhibited, and synthesis of host DNA was not stimulated. To enhance propagation of type 2 adenovirus, synthesis of an early SV40 protein was essential; 50 mug of cycloheximide per ml prevented the SV40-induced enhancement of adenovirus multiplication, whereas 5 x 10(-6)m 5-fluoro-2-deoxyuridine did not abrogate the enhancing phenomenon.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4315958      PMCID: PMC376044     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  A fractionating column for analysis of nucleic acids.

Authors:  J D MANDELL; A D HERSHEY
Journal:  Anal Biochem       Date:  1960-06       Impact factor: 3.365

3.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

4.  Mechanism by which fiber antigen inhibits multiplication of type 5 adenovirus.

Authors:  A J Levine; H S Ginsberg
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

5.  Characterization of a Tumorlike Antigen in Type 12 and Type 18 Adenovirus-Infected Cells.

Authors:  Z Gilead; H S Ginsberg
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

6.  Interaction of a simian papovavirus and adenoviruses. I. Induction of adenovirus tumor antigen during abortive infection of simian cells.

Authors:  L A Feldman; J S Butel; F Rapp
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

7.  Studies on the mechanism of enhancement of adenovirus 7 infection in African green monkey cells by simian virus 40: formation of adenovirus-specific RNA.

Authors:  S G Baum; W H Wiese; P R Reich
Journal:  Virology       Date:  1968-02       Impact factor: 3.616

8.  Induction of cellular deoxyribonuleic acid synthesis by simian virus 40.

Authors:  S Kit; R A De Torres; D R Dubbs; M L Salvi
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

9.  Synthesis of virus deoxyribonucleic acid during abortive infection of simian cells by human adenoviruses.

Authors:  F Rapp; L A Feldman; M Mandel
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

10.  Adeno-associated satellite virus interference with the replication of its helper adenovirus.

Authors:  W P Parks; A M Casazza; J Alcott; J L Melnick
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more
  49 in total

1.  Characterization of a variant of human adenovirus type 2 which multiples efficiently in simian cells.

Authors:  D F Klessig; J A Hassell
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

2.  Hexon peptides of type 2, 3, and 5 adenoviruses and their relationship to hexon structure.

Authors:  M F Stinski; H S Ginsberg
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

3.  Post-transcriptional restriction of human adenovirus expression in monkey cells.

Authors:  L Eron
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

4.  Simian virus 40 DNA replication, transcription, and antigen induction during infection with two adenovirus 2-SV40 hybrids that contain the entire SV40 genome.

Authors:  S E Siegel; C T Patch; A M Lewis; A S Levine
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

5.  Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells.

Authors:  J M Johnston; K P Anderson; D F Klessig
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

6.  Synthesis of type 2 adenovirus DNA in the presence of cycloheximide.

Authors:  M S Horwitz; C Brayton; S G Baum
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

7.  Studies of the mechanism of enhancement of human adenovirus infection in monkey cells by simian virus 40.

Authors:  S G Baum; M S Horwitz; J V Maizel
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

8.  Synthesis of viral ribonucleic acid during restricted adenovirus infection.

Authors:  R I Fox; S G Baum
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Transcription and transport of virus-specific ribonucleic acids in African green monkey kidney cells abortively infected with type 2 adenovirus.

Authors:  J J Lucas; H S Ginsberg
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

10.  Adenovirus DNA-binding protein in cells infected with wild-type 5 adenovirus and two DNA-minus, temperature-sensitive mutants, H5ts125 and H5ts149.

Authors:  H S Ginsberg; U Lundholm; T Linné
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.